Carl Feng
banner
fenglab.bsky.social
Carl Feng
@fenglab.bsky.social
Immunologist @ University of Sydney interested in host defence against infection
New preprint from my lab on mapping immune cell organization in the lungs of tuberculosis patients using spatial proteomics, a productive collaboration with Xinchun Chen lab and @ellispatrick.bsky.social
www.biorxiv.org/content/10.1...
Tissue-wide profiling of human lungs reveals spatial sequestration of macrophages in tuberculosis
The immune response to human tuberculosis (TB), particularly in the context of complex lung pathology, remains incompletely understood. Here, we employed whole-slide spatial proteomics to map immune c...
www.biorxiv.org
April 16, 2025 at 5:15 AM
Reposted by Carl Feng
New preprint from Clare Smith’s lab on Cathepsin Z as a TB host susceptibility locus - cool collaboration with Hawn and Stein labs @dukemedschool.bsky.social
www.biorxiv.org/content/10.1...
Cathepsin Z is a conserved susceptibility factor underlying tuberculosis severity
Tuberculosis (TB) outcomes vary widely, from asymptomatic infection to mortality, yet most animal models do not recapitulate human phenotypic and genotypic variation. The genetically diverse Collaborative Cross mouse panel models distinct facets of TB disease that occur in humans and allows identification of genomic loci underlying clinical outcomes. We previously mapped a TB susceptibility locus on mouse chromosome 2. Here, we identify cathepsin Z ( Ctsz ) as a lead candidate underlying this TB susceptibility and show that Ctsz ablation leads to increased bacterial burden, CXCL1 overproduction, and decreased survival in mice. Ctsz disturbance within murine macrophages enhances production of CXCL1, a known biomarker of TB severity. From a Ugandan household contact study, we identify significant associations between CTSZ variants and TB disease severity. Finally, we examine patient-derived TB granulomas and report CTSZ localization within granuloma-associated macrophages, placing human CTSZ at the host-pathogen interface. These findings implicate a conserved CTSZ-CXCL1 axis in humans and genetically diverse mice that mediates TB disease severity. ### Competing Interest Statement The authors have declared no competing interest.
www.biorxiv.org
April 3, 2025 at 9:34 PM
Reposted by Carl Feng
We've known about the gut-brain axis.
Now we're learning about the gut-brain-lung axis whereby food intake can trigger an immune response in the airway. www.cell.com/neuron/fullt...
March 9, 2025 at 4:21 PM
Reposted by Carl Feng
Interested in Mtb pathogenesis and developing new strategies to treat these deadly infections? Please apply to join us for the GRC for Tuberculosis Drug Discovery and Development!! www.grc.org/tuberculosis...
Deadline to submit an abstract to be considered for a talk is March 1st! Please repost!
2025 Tuberculosis Drug Discovery and Development Conference GRC
The 2025 Gordon Research Conference on Tuberculosis Drug Discovery and Development will be held in Castelldefels, Barcelona Spain. Apply today to reserve your spot.
www.grc.org
January 10, 2025 at 5:14 PM
Reposted by Carl Feng
1/ We are excited to share our new paper in @jexpmed.bsky.social about humans with autosomal dominant IFNAR1 deficiency (doi.org/10.1084/jem....).
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity | Journal of Experimental Medicine | Rockefeller University Press
This study identifies 11 IFNAR1 alleles impairing IFN-α/ω responses but sparing IFN-β, including an allele common in Southern China (P335del). Heterozygous
doi.org
December 17, 2024 at 3:11 PM
Reposted by Carl Feng
Cold Spring Harbor Asia meeting on Mycobacterial Pathogenesis and Host Response, Suzhou, China, March 17-21, 2025. Abstract deadline Jan 10, 2025. www.csh-asia.org?content/2606
December 16, 2024 at 9:41 AM
Reposted by Carl Feng
Interested in the immunopathology of human tuberculosis? Here is our latest review:
www.science.org/doi/10.1126/...
Immunopathology in human tuberculosis
The balance between protective and pathological immune responses shapes progression of Mycobacterium tuberculosis infection.
www.science.org
December 13, 2024 at 10:59 PM
Reposted by Carl Feng
Applications are open for the 2025 TB drug discovery & development GRC!! We have an awesome line-up of speakers and multiple open talk slots that will be filled based on abstract submissions. Apply now to join us for this fantastic conference!! www.grc.org/tuberculosis...
2025 Tuberculosis Drug Discovery and Development Conference GRC
The 2025 Gordon Research Conference on Tuberculosis Drug Discovery and Development will be held in Castelldefels, Barcelona Spain. Apply today to reserve your spot.
www.grc.org
November 24, 2024 at 11:45 PM
Reposted by Carl Feng
#WeekendRead! #LocationLocationLocation! Amazing @Nature by @touficmayassi.bsky.social, Xavier &co showing regional specialization of the gut at the spatial (single cell) level! Strong resilience after inflammation & ILC2 are key in middle colon adaption to microbiota! www.nature.com/articles/s41...
Spatially restricted immune and microbiota-driven adaptation of the gut - Nature
Intestinal regionalization is characterized by robust and resilient structural cell states and the intestine can adapt to environmental stress in a spatially controlled manner through crosstalk betwee...
www.nature.com
November 23, 2024 at 2:56 PM